Your browser doesn't support javascript.
loading
Cardiac Tamponade and Duodenal Hemorrhage Caused by Inappropriate Use of Dabigatran in a Patient With End-Stage Renal Failure: A Case Report.
Hayashida, Marina; Suzuki, Masataka; Nakata, Yosuke; Kakita, Hiroko; Eizawa, Hiroshi.
Afiliación
  • Hayashida M; Nephrology, Kobe City Nishi-Kobe Medical Center, Kobe, JPN.
  • Suzuki M; Cardiology, Kobe City Nishi-Kobe Medical Center, Kobe, JPN.
  • Nakata Y; Nephrology, Kobe City Nishi-Kobe Medical Center, Kobe, JPN.
  • Kakita H; Nephrology, Kobe City Nishi-Kobe Medical Center, Kobe, JPN.
  • Eizawa H; Cardiology, Kobe City Nishi-Kobe Medical Center, Kobe, JPN.
Cureus ; 16(1): e52521, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38371033
ABSTRACT
A 72-year-old man with end-stage renal failure, receiving 220 mg of dabigatran for chronic atrial fibrillation, was admitted with generalized edema and shortness of breath. Cardiac tamponade caused by pericardial hemorrhage due to inappropriate dabigatran use was treated with pericardial drainage and idarucizumab. Although coagulability normalized, consecutive duodenal hemorrhages occurred, requiring arterial embolization for hemostasis. In cases of severely impaired renal function, the usual dose of idarucizumab may not be sufficient to reverse the effects of dabigatran. Therefore, we considered the need for repeated idarucizumab administration to prevent recurrent bleeding.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article
...